
Please try another search
MaaT Pharma SA, a late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival. Its products pipeline includes MaaT013, that is in pivotal phase 3 clinical trial for the treatment of acute graft versus host diseases with gastrointestinal involvement; MaaT033, which is in phase 2b clinical trial for the improvement of survival in patients with acute myeloid leukemia or blood cancer receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors, as well as MaaT034 that optimize immune checkpoint inhibitor treatment. The company was incorporated in 2014 and is headquartered in Lyon, France.
Name | Age | Since | Title |
---|---|---|---|
Pierre Belichard | - | - | Co-Founder and Chairman of the Board |
Herve Affagard | 51 | 2014 | CEO, Co-Founder & Director |
Joel Dore | - | - | Co-Founder & Member of Scientific Advisory Board |
Robert Zeiser | - | 2020 | Member of Scientific Advisory Board |
Ernst Holler | - | 2020 | Chair of Scientific Advisory Board |
Robert Jenq | - | 2020 | Member of Scientific Advisory Board |
Dorothee Burkel | 61 | 2021 | Independent Non Executive Director |
Florent Malard | - | 2020 | Member of Scientific Advisory Board |
Jean Volatier | 60 | 2021 | Independent Non Executive Director |
Jean-Marie Lefevre | 65 | 2016 | Chairman of the Board |
Hassane Zarour | - | 2022 | Member of Scientific Advisory Board |
Jonathan Peled | - | - | Member of Advisory Board |
Nadia Kamal | 54 | 2023 | Independent Director |
Claude Bertrand | 63 | 2020 | Independent Non-Executive Director |
Isabelle de Cremoux | 55 | 2014 | Representative Director |
Muriel Prudent | 39 | - | Representative Director |
Mohamad Mohty | - | - | Member of Advisory Board (Medical Hematology – Oncology Advisor) |
Franck Carbonnel | - | 2022 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review